Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003448314 | SCV004175923 | likely benign | Rett syndrome | 2023-10-13 | reviewed by expert panel | curation | The p.Pro362Ser variant in MECP2 (NM_004992.3) is present in 1 XX and 1 XY individual in gnomAD (0.0011%) (not sufficient to meet BS1 criteria). The p.Pro362Ser variant in MECP2 is observed in at least 3 unaffected individuals (internal database - Invitae) (BS2). In the absence of conflicting evidence, this is sufficient evidence to classify as likely benign based on the specifications defined by the ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel. In summary, the p.Pro362Ser variant in MECP2 is classified as Likely Benign based on the ACMG/AMP criteria (BS2). |
Gene |
RCV000493837 | SCV000581980 | uncertain significance | not provided | 2017-04-27 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the MECP2 gene. The P362S variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The P362S variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The P362S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Diagnostic Laboratory, |
RCV001257760 | SCV001434572 | likely benign | Intellectual disability | 2020-04-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001312686 | SCV001503150 | likely benign | Severe neonatal-onset encephalopathy with microcephaly | 2023-09-08 | criteria provided, single submitter | clinical testing |